BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37598478)

  • 1. Immune microenvironment of cervical cancer and the role of IL-2 in tumor promotion.
    Trujillo-Cirilo L; Weiss-Steider B; Vargas-Angeles CA; Corona-Ortega MT; Rangel-Corona R
    Cytokine; 2023 Oct; 170():156334. PubMed ID: 37598478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that the viral oncoproteins E6 and E7 of HPV induce the expression of a functional IL-2R on cervical cancer cells.
    Trujillo-Cirilo L; Torres-Corioriles EI; Rangel-Corona R; Corona-Ortega MT; Weiss-Steider B
    Cytokine; 2021 Dec; 148():155592. PubMed ID: 34099345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins.
    Gutiérrez-Hoya A; Soto-Cruz I
    Cells; 2020 Oct; 9(10):. PubMed ID: 33076315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropic Effects of IL-2 on Cancer: Its Role in Cervical Cancer.
    Valle-Mendiola A; Gutiérrez-Hoya A; Lagunas-Cruz Mdel C; Weiss-Steider B; Soto-Cruz I
    Mediators Inflamm; 2016; 2016():2849523. PubMed ID: 27293315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
    Ren C; Cheng X; Lu B; Yang G
    Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the Single-Cell Transcriptome Network of Immune Environment Underlying Cervical Premalignant Lesion, Cervical Cancer and Metastatic Lymph Nodes.
    Li C; Hua K
    Front Immunol; 2022; 13():897366. PubMed ID: 35812401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-23 and the Tumor Microenvironment.
    Subhadarshani S; Yusuf N; Elmets CA
    Adv Exp Med Biol; 2021; 1290():89-98. PubMed ID: 33559857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus.
    Valle-Mendiola A; Gutiérrez-Hoya A; Soto-Cruz I
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma.
    Berti FCB; Pereira APL; Cebinelli GCM; Trugilo KP; Brajão de Oliveira K
    Cytokine Growth Factor Rev; 2017 Apr; 34():1-13. PubMed ID: 28365229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.
    Morgan EL; Macdonald A
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32899142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer.
    Rocha-Zavaleta L; Huitron C; Cacéres-Cortés JR; Alvarado-Moreno JA; Valle-Mendiola A; Soto-Cruz I; Weiss-Steider B; Rangel-Corona R
    Cell Signal; 2004 Nov; 16(11):1239-47. PubMed ID: 15337523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E6/E7 and E6
    Artaza-Irigaray C; Molina-Pineda A; Aguilar-Lemarroy A; Ortiz-Lazareno P; Limón-Toledo LP; Pereira-Suárez AL; Rojo-Contreras W; Jave-Suárez LF
    Front Immunol; 2019; 10():1676. PubMed ID: 31396215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased number of IL-2, IL-2 receptor and IL-10 positive cells in premalignant lesions of the cervix.
    Mindiola R; Caulejas D; Núñez-Troconis J; Araujo M; Delgado M; Mosquera J
    Invest Clin; 2008 Dec; 49(4):533-45. PubMed ID: 19245171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel role of metalloproteinase in cancer-mediated immunosuppression.
    Sheu BC; Hsu SM; Ho HN; Lien HC; Huang SC; Lin RH
    Cancer Res; 2001 Jan; 61(1):237-42. PubMed ID: 11196168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10.
    Ravi VM; Neidert N; Will P; Joseph K; Maier JP; Kückelhaus J; Vollmer L; Goeldner JM; Behringer SP; Scherer F; Boerries M; Follo M; Weiss T; Delev D; Kernbach J; Franco P; Schallner N; Dierks C; Carro MS; Hofmann UG; Fung C; Sankowski R; Prinz M; Beck J; Salié H; Bengsch B; Schnell O; Heiland DH
    Nat Commun; 2022 Feb; 13(1):925. PubMed ID: 35177622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jeg-3 human choriocarcinoma-induced immunosuppression: downregulation of interleukin-2, interleukin-2 receptor alpha-chain, and its Jak/Stat signaling pathway.
    Kilic M; Flossmann E; Flossmann O; Vogelsang H; Junker U; Chaouat G; Markert UR
    Am J Reprod Immunol; 1999 Jan; 41(1):61-9. PubMed ID: 10097788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of gamma interferon but not interleukin-10 expression in response to human papillomavirus type 11 E6 protein in respiratory papillomatosis.
    DeVoti JA; Steinberg BM; Rosenthal DW; Hatam L; Vambutas A; Abramson AL; Shikowitz MJ; Bonagura VR
    Clin Diagn Lab Immunol; 2004 May; 11(3):538-47. PubMed ID: 15138179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that cervical cancer cells secrete IL-2, which becomes an autocrine growth factor.
    Rangel-Corona R; Corona-Ortega T; Soto-Cruz I; López-Labra A; Pablo-Arcos T; Torres-Guarneros CF; Weiss-Steider B
    Cytokine; 2010 Jun; 50(3):273-7. PubMed ID: 20227890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene.
    Lee S; Kim JH; Kim H; Kang JW; Kim SH; Yang Y; Kim J; Park J; Park S; Hong J; Yoon DY
    Immunology; 2011 Mar; 132(3):410-20. PubMed ID: 21208204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.